Welcome to the Genome Stability Group pages

Our research focuses on understanding how cells maintain integrity of their genomes in the face of internal and external damage, originating e.g. during DNA replication or upon exposure to chemotherapeutic agents. We use both basic science and translational approaches, the latter concentrating on high-grade serous ovarian cancer patient samples. Our aim is to provide biological insights that will be useful in clinical decision-making, either immediately or in the longer term.
Read more
@LabKauppi

Elli's paper is out now in its final form. Of replication errors, mismatch repair and H3K36me3!! Single-Cell Sequ… twitter.com/i/web/status/1…

Congratulations to the Keeney (@Spo11Rulz) and Jasin labs on yet another insightful paper on pseudoautosomal region… twitter.com/i/web/status/1…

CHEMORESPONSE-hankkeessa luodaan malli, jonka avulla kullekin munasarjasyöpäpotilaalle voidaan suunnitella hänen sy… twitter.com/i/web/status/1…

This #WorldCancerDay we want to thank all cancer researchers and medical professionals. These are the people curin… twitter.com/i/web/status/1…

@TERVA_OvCa

Viikon jutussa akatemiatutkija ja Terva Chemoresponse konsortiumin johtaja Liisa Kauppi pohtii mitkä ominaisuudet y… twitter.com/i/web/status/1…

Sign up for the virtual minisymposium on 18.11. organised by Research Program in Systems Oncology & Department of O… twitter.com/i/web/status/1…

Tärkeä edistysaskel syöpäpotilaiden hoidossa! @HUS_uutisoi @HBiopankki @FicanSouth @iCAN_Finlandtwitter.com/i/web/status/1…

”Me välitämme.” Roosa nauha rinnassa on osoitus tuestamme syöpään sairastuneille ja siitä, että olemme kaikki muka… twitter.com/i/web/status/1…

Recent publications

RSS Feed

No results.